HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cancer Of The Eye

Cancer of the eye, also known as ocular cancer, is a rare but serious condition that can affect various parts of the eye, including the eyelid, conjunctiva, and the eyeball itself. This type of cancer can manifest in different forms, such as melanoma, squamous cell carcinoma, and lymphoma. Symptoms of eye cancer may include changes in vision, eye pain, redness, and the presence of a visible mass or growth on the eye. However, it's important to note that these symptoms can be caused by various eye conditions, and not all eye issues are indicative of cancer. Diagnosis typically involves a thorough eye examination by an ophthalmologist, who may use imaging tests such as ultrasound, CT scans, or MRI to assess the extent of the cancer. In some cases, a biopsy may be performed to confirm the diagnosis. Treatment options for eye cancer depend on the type and stage of the cancer. Common approaches include surgery to remove the tumor, radiation therapy, and in some cases, chemotherapy. Early detection and prompt intervention are crucial for a better prognosis. While eye cancer is relatively rare, certain risk factors may increase the likelihood of its development. These factors include prolonged exposure to ultraviolet (UV) radiation, a weakened immune system, and a family history of eye cancer. Regular eye examinations and protecting your eyes from excessive UV exposure by wearing sunglasses can contribute to prevention. If any unusual symptoms or changes in vision occur, it's essential to seek prompt medical attention. A timely diagnosis and appropriate treatment can significantly improve the chances of successful management and recovery from eye cancer.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp